Back to Search Start Over

Hemizygosity for SMCHD1 in Facioscapulohumeral Muscular Dystrophy Type 2: Consequences for 18p Deletion Syndrome.

Authors :
Lemmers RJ
van den Boogaard ML
van der Vliet PJ
Donlin-Smith CM
Nations SP
Ruivenkamp CA
Heard P
Bakker B
Tapscott S
Cody JD
Tawil R
van der Maarel SM
Source :
Human mutation [Hum Mutat] 2015 Jul; Vol. 36 (7), pp. 679-83. Date of Electronic Publication: 2015 May 20.
Publication Year :
2015

Abstract

Facioscapulohumeral muscular dystrophy (FSHD) is most often associated with variegated expression in somatic cells of the normally repressed DUX4 gene within the D4Z4-repeat array. The most common form, FSHD1, is caused by a D4Z4-repeat array contraction to a size of 1-10 units (normal range 10-100 units). The less common form, FSHD2, is characterized by D4Z4 CpG hypomethylation and is most often caused by loss-of-function mutations in the structural maintenance of chromosomes hinge domain 1 (SMCHD1) gene on chromosome 18p. The chromatin modifier SMCHD1 is necessary to maintain a repressed D4Z4 chromatin state. Here, we describe two FSHD2 families with a 1.2-Mb deletion encompassing the SMCHD1 gene. Numerical aberrations of chromosome 18 are relatively common and the majority of 18p deletion syndrome (18p-) cases have, such as these FSHD2 families, only one copy of SMCHD1. Our finding therefore raises the possibility that 18p- cases are at risk of developing FSHD. To address this possibility, we combined genome-wide array analysis data with D4Z4 CpG methylation and repeat array sizes in individuals with 18p- and conclude that approximately 1:8 18p- cases might be at risk of developing FSHD.<br /> (© 2015 WILEY PERIODICALS, INC.)

Details

Language :
English
ISSN :
1098-1004
Volume :
36
Issue :
7
Database :
MEDLINE
Journal :
Human mutation
Publication Type :
Academic Journal
Accession number :
25820463
Full Text :
https://doi.org/10.1002/humu.22792